Patents by Inventor Charles Wang Ma

Charles Wang Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170147768
    Abstract: Disclosed are a method and a system using user personal, CBC, CMP and Lipid Panel data to detect a user acute myocardial infarction (AMI) risk and help user monitor AMI risk. Most AMI risk screening and diagnosis are related with the markers, video, image data, etc. although past researches have shown that serum albumin, RBC, MCV, MPV and PDW are all significantly correlated with AMI risk, use of the blood test results of CBC, CMP and Lipid Panel data to detect and monitor AMI risk has never been reported. Traditionally, AMI risk detecting and monitoring have been managed by doctors and hospitals and a user is unable to do it by himself or herself. The purpose of this invention is to provide an intelligent AMI risk detecting and monitoring system enabling users to detect and monitor AMI risk.
    Type: Application
    Filed: February 6, 2017
    Publication date: May 25, 2017
    Inventors: Liwei Ma, Charles Wang Ma, Young Young Ma
  • Publication number: 20170140115
    Abstract: Disclosed are a method and a system using user personal, CBC, CMP and Lipid Panel data to predict a user stroke risk and help user monitor the stroke risk. Most stroke screening and diagnosis are related with the markers, video, image data, etc. although past researches have shown that serum albumin, RBC, MCV, MPV and PDW are all significantly correlated with stroke, use of the blood test results of CBC, CMP and Lipid Panel data to predict and monitor stroke risk has never been reported. Traditionally, stroke risk prediction and monitoring have been managed by doctors and hospitals and a user is unable to do it by himself or herself. The purpose of this invention is to provide an intelligent stroke risk prediction and monitoring system enabling users to predict and monitor the stroke risk.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 18, 2017
    Inventors: Liwei Ma, Charles Wang Ma, Young Young Ma
  • Publication number: 20160110516
    Abstract: Disclosed are a method and a system for monitoring early cancer risk. Most current early cancer detection and diagnosis are related with gene and biomarkers, although the practice has proven the significant differences of blood and urine test results between cancer patients and healthy people, and obtaining the results of routine blood and urine tests is not difficult, the use of routine blood and urine tests to detect and monitor early cancer risk has never been reported; and traditionally, early cancer detection and monitoring have been managed by doctors and hospitals, the users are unable to do it themselves. The purpose of this invention is to provide an early cancer risk monitoring system enabling users to dynamic monitor the early cancer risk.
    Type: Application
    Filed: October 20, 2014
    Publication date: April 21, 2016
    Inventors: Liwei Ma, Charles Wang Ma